ROP.SW ROCHE PS
Healthcare · Drug Manufacturers - General
367.40
+1.80%
About the company
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
52-week range
Dividend deep dive
ROCHE PS (ROP.SW), operating in the Drug Manufacturers - General industry within the Healthcare sector, currently offers a dividend yield of 2.93%. This yield falls within its 5-year historical range of 2.68% (low) to 3.75% (high), and Yield Theory assesses its current status as "fair." The company's dividend safety is rated as "safe." Its market capitalization is not provided in the available data.
Dividend history
ROCHE PS has maintained a consistent record of dividend increases for 28 consecutive years, earning it a "champion" tier classification. The company distributes dividends annually, typically in March. Its dividend growth has been modest, with a 3-year Compound Annual Growth Rate (CAGR) of 1.41% and a 5-year CAGR of 1.51%. The annual dividend per share has progressed from CHF 7.8 in 2014 to CHF 9.5 in 2023, with CHF 9.6 projected for 2024 and CHF 9.7 for 2025.
Dividend safety
The dividend coverage for ROCHE PS appears robust, with a payout ratio of 61.06% against its earnings, contributing to its "safe" dividend safety status. The balance sheet indicates a debt-to-equity ratio of 87.637%.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 17 Jul 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Payment calendar
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
Held by 1 investor · watched by 1
Appears in these lists
ROP.SW qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track ROP.SW and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →